- Professor Lees receives Jay Van Andel Award for Outstanding Research in Parkinson’s Disease
- Creating brain cells from skin to study Alzheimer's
- Queen Square authors prominent in Brain collection of classic articles
- Toxic proteins implicated in frontotemporal dementia and motor neurone disease
- Double mutation linked to frontotemporal dementia
- Equation to predict happiness
- Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia
- Researchers test whether diabetes drug can help Parkinson’s patients
- Acute optic neuritis: a review and proposed protocol
- Hippocampal subfield size predicts the precision of memory recall
- Immune system implicated in dementia development
- UCL and Chiesi Group announce partnership to develop a novel therapeutic for birth asphyxia
- Professor Golay made a Fellow of the ISMRM
- The new Leonard Wolfson Experimental Neurology Centre (LWENC) has opened for clinical studies and trials
- Professor Rees wins UCLU Student Choice Teaching Award
- New epilepsy treatment offers ‘on demand’ seizure suppression
- Professor Tabrizi and Professor Price elected to Fellowship of the Academy of Medical Sciences.
- Professor Dolan and Professor Friston elected to EMBO membership
- Vitamin B3 treatment for ataxia shows promise in first human trial
- Teaching Awards 2014
- Light-activated neurons from stem cells restore function to paralysed muscles
- UCL and Max Planck Society invest €5m to open world’s first computational psychiatry centre
- Successful launch of new annual leading edge neurology course
- Statins could help control MS
- Professor Hardy awarded Thudichum Medal by Biochemical Society
- Population Screening for vCJD Using a Novel Blood Test
- Chief Medical Officer appoints Professor Rossor as NIHR National Director for Dementia Research
- New partnership between UCLP brain tumour scientists and Brain Tumour Research
- Professor Hardy awarded Dan David Prize for work on the amyloid gene encoding APP
- NIHR award £650,000 for research into rare neurodegenerative and neuromuscular diseases
- Lowering levels of toxic protein reverses abnormalities in cells from patients with Huntington's disease
- Major initiative in understanding synaptic basis of neuropsychiatric disease
- Visit to the Berlin School of Mind and Brain
- Institute of Neurology ranked as the world’s top institution for epilepsy research.
- Predicting age at onset in SCA1 : does size matter?
- UCL takes the lead with £8.5m funding for dementia research
- Secretary of State visits leading dementia research projects
- Riboflavin Treatment for Childhood onset Motor Neuron Disease
- Dreading pain can be worse than pain itself
- Different gene expression in male and female brains helps explain differences in brain disorders
- New £20m centre pioneers first-in-man trials for neurodegenerative diseases
- RNA build-up linked to dementia and motor neuron disease
- Researchers estimate one in 2,000 people in the UK carry variant CJD proteins
- Professor Alan Thompson discusses Atlas of MS on Lancet News
- Wellcome Trust Principal Fellowship award to explore neural coding with the tripartite synapse
- Marsden's Book of Movement Disorders wins Neurology first prize at the 2013 BMA Book Awards
- Scientists develop refined diagnostic tool for inherited dementias
- Genetic mutations linked to Parkinson's Disease
- P-glycoprotein over-activity and drug resistance in temporal lobe epilepsy
- New Yale-UCL collaboration in brain aneurysm genetics
- ‘Risky’ stroke prevention procedure may be safe in some patients
- The Michael J. Fox Foundation awards grant for Exenatide research
- Institute Professor leads cross-disciplinary study on use of glucose in detecting cancer.
- Irreversible tissue loss seen within 40 days of spinal cord injury
- From Bedside to Bench in the Institute’s MRC Centre for Neuromuscular Diseases
- Centralising acute stroke services has saved more than 400 lives since 2010
- Rapid Response Innovation Award from The Michael J. Fox Foundation
- Predicting Language Outcome and Recovery After Stroke (PLORAS) project launches new website
- BRC awards over £500k to neuroscience projects
- ABTA Winners
- Diabetes drug could help treat Parkinson's Disease
- Clinical trials are vital tools in stroke research
- New gene identified for Dominant Congenital Spinal Muscular Atrophy and Hereditary Spastic Paraparesis
- Teaching Awards 2013
- 14th Annual Queen Square Symposium
- TRACK-HD study identifies early predictors of disease progression in Huntington’s disease
- The Great Brain Experiment: crowdsourcing data on how we think and act
- Psychogenic diseases linked to abnormal brain activity
- Human Brain Project wins major EU funding
- Gene mutation causes familial form of cranio-cervical dystonia
- Professor Ray Dolan awarded prestigious Klaus Joachim Zülch Prize
- Professor Dimitri Kullmann elected Editor of Brain
- IoN News Archive (2012)
- IoN News Archive (2011)
- IoN News Archive (2010)
- IoN News Archive (2009)
- GCH1 gene and Parkinson’s risk
- Brain stimulation to improve cognition in dementia
Published: Aug 12, 2014 1:23:13 PM
Published: Feb 20, 2014 6:58:34 PM
Published: Sep 16, 2013 1:37:21 PM
Published: Feb 24, 2014 2:53:53 PM
Published: Jul 16, 2014 5:42:14 PM
Published: Sep 3, 2014 11:00:13 AM
Chief Medical Officer appoints Professor Rossor as NIHR National Director for Dementia Research
4 March 2014
Dame Sally Davies, the Chief Medical Officer, has appointed Professor Martin Rossor (UCL Institute of Neurology) as the new NIHR National Director for Dementia Research.
This new post will provide the leadership needed to facilitate and support the Department of Health’s research response to commitments under the Prime Minister’s Dementia Challenge and the G8 Dementia Summit. This will involve activity across NIHR activity as well as work with single components of NIHR. Other work will involve engagement with external stakeholders, such as NHS England, research charities and other research funders, including industry. Martin will draw on the expertise of the Evington Group, and work with the Dementia Innovation Envoy.
Professor Rossor will work closely with staff in the DH R&D Directorate, with the NIHR Clinical Research Network, particularly Jonathan Sheffield and Ian McKeith, and with other NIHR research infrastructure, especially Simon Lovestone and the NIHR Dementia Translational Research Collaboration, as well as Alistair Burns, NHS England’s National Clinical Director for Dementia.
The initial focus of effort will be on:
1. International Action Plan: Contributing to the development of an international action plan for research, which will account for the current state of science and promote global efforts to maintain brain health and find therapies for dementia.
2. Championing research: Working with clinical academics and the NHS.
3. Patients and their data: Improving recruitment of patients into research through building on the NHS Constitution pledge to inform patients about opportunities to participate in research and engaging the NHS in the implementation of RAFT (the Recruitment & Feasibility Tool – a database for patients to register their interest in dementia research).
4. Facilitating clinical research: Working with the Translational Research Collaboration and the NIHR Clinical Research Network towards achieving common research platforms; working within current frameworks for consent and use of data to promote sharing of data from existing research.
5. Living Well with Dementia: Facilitating research to support living well with dementia initiatives and identifying effective interventions, in the clinic, in the nursing home, and in everyday life.
6. Building research capacity and addressing other barriers to research progress.
The responsibility for the research and infrastructure funded by NIHR will remain with individuals leading the research and the relevant NIHR initiatives.
Martin will be supported by a small staff.
Page last modified on 04 mar 14 10:03